Publication May 5, 2026

Acetyl Hexapeptide-8 Featured in New Skin Permeability Study

Drafted by an automated content engine from FDA, PubChem, ClinicalTrials.gov, NIH DSLD, and Open Beauty Facts data.

A new publication involving acetyl hexapeptide-8 was released on May 5, 2026. The paper, titled "Ex Vivo Evaluation of Skin Permeability Enhancement Using TargetCool in Human-Derived Skin Tissue Models," appeared in The Journal of Craniofacial Surgery.

The publication is identified by PubMed ID 42084412 and is listed as a new addition to the scientific literature. According to the event data, the study used human-derived skin tissue models to evaluate skin permeability enhancement in an ex vivo setting.

No findings, outcomes, or conclusions from the study have been provided beyond the title and journal listing itself. This brief does not summarize or infer any results, efficacy, or safety data since none were included in the available event information.

Readers interested in this publication can access the full text through the source link provided.

For more background on acetyl hexapeptide-8, readers can consult the compound overview.

See the full acetyl hexapeptide-8 overview

Source: https://pubmed.ncbi.nlm.nih.gov/42084412/